99
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Sex-related differences in management of Swedish patients with a clinical diagnosis of chronic obstructive pulmonary disease

, , , , , & show all
Pages 961-969 | Published online: 07 May 2019

References

  • Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):020415. doi:10.7189/jogh.05.02041526755942
  • Backman H, Eriksson B, Ronmark E, et al. Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden. Respir Med. 2016;114:103–110. doi:10.1016/j.rmed.2016.03.01327109819
  • Danielsson P, Olafsdottir IS, Benediktsdottir B, Gislason T, Janson C. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden – the burden of obstructive lung disease (BOLD) study: cross-sectional population-based study. Clin Respir J. 2012;6(2):120–127. doi:10.1111/j.1752-699X.2011.00257.x21651748
  • Stallberg B, Janson C, Johansson G, et al. Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS). Prim Care Respir J. 2014;23(1):38–45. doi:10.4104/pcrj.2013.0010624346825
  • Raghavan D, Varkey A, Bartter T. Chronic obstructive pulmonary disease: the impact of gender. Curr Opin Pulm Med. 2017;23(2):117–123. doi:10.1097/MCP.000000000000035327977622
  • Martinez CH, Raparla S, Plauschinat CA, et al. Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. J Womens Health. 2012;21(12):1267–1274. doi:10.1089/jwh.2012.3650
  • Celli B, Vestbo J, Jenkins CR, et al. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med. 2011;183(3):317–322. doi:10.1164/rccm.201004-0665OC20813884
  • Aryal S, Diaz-Guzman E, Mannino DM. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis. 2014;9:1145–1154. doi:10.2147/COPD.S5447625342899
  • Roberts NJ, Patel IS, Partridge MR. The diagnosis of COPD in primary care; gender differences and the role of spirometry. Respir Med. 2016;111:60–63. doi:10.1016/j.rmed.2015.12.00826733228
  • de Torres JP, Casanova C, Montejo de Garcini A, Aguirre-Jaime A, Celli BR. Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease. Respir Res. 2007;8:18. doi:10.1186/1465-9921-8-9117341300
  • Han MK, Arteaga-Solis E, Blenis J, et al. Female sex and gender in lung/sleep health and disease. Increased understanding of basic biological, pathophysiological, and behavioral mechanisms leading to better health for female patients with lung disease. Am J Respir Crit Care Med. 2018;198(7):850–858. doi:10.1164/rccm.201801-0168WS29746147
  • Brannstrom J, Hamberg K, Molander L, Lovheim H, Gustafson Y. Gender disparities in the pharmacological treatment of cardiovascular disease and diabetes mellitus in the very old: an epidemiological, cross-sectional survey. Drugs Aging. 2011;28(12):993–1005. doi:10.2165/11594730-000000000-0000022117097
  • Lindberg E, Benediktsdottir B, Franklin KA, et al. Women with symptoms of sleep-disordered breathing are less likely to be diagnosed and treated for sleep apnea than men. Sleep Med. 2017;35:17–22. doi:10.1016/j.sleep.2017.02.03228619177
  • Henoch I, Strang S, Lofdahl CG, Ekberg-Jansson A. Management of COPD, equal treatment across age, gender, and social situation? A register study. Int J Chron Obstruct Pulmon Dis. 2016;11:2681–2690. doi:10.2147/COPD.S11523827822030
  • Dales RE, Mehdizadeh A, Aaron SD, Vandemheen KL, Clinch J. Sex differences in the clinical presentation and management of airflow obstruction. Eur Respir J. 2006;28(2):319–322. doi:10.1183/09031936.06.0013810516880366
  • Sundh J, Johansson G, Larsson K, et al. Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units. Int J Chron Obstruct Pulmon Dis. 2015;10:173–183. doi:10.2147/COPD.S7464525653516
  • Sundh J, Janson C, Lisspers K, Stallberg B, Montgomery S. The dyspnoea, obstruction, smoking, exacerbation (DOSE) index is predictive of mortality in COPD. Prim Care Respir J. 2012;21(3):295–301. doi:10.4104/pcrj.2012.0005422786813
  • Sundh J, Janson C, Lisspers K, Montgomery S, Stallberg B. Clinical COPD questionnaire score (CCQ) and mortality. Int J Chron Obstruct Pulmon Dis. 2012;7:833–842. doi:10.2147/COPD.S3811923277739
  • Sundh J, Osterlund Efraimsson E, Janson C, Montgomery S, Stallberg B, Lisspers K. Management of COPD exacerbations in primary care: a clinical cohort study. Prim Care Respir J. 2013;22(4):393–399. doi:10.4104/pcrj.2013.0008724114334
  • Sundh J, Stallberg B, Lisspers K, Kampe M, Janson C, Montgomery S. Comparison of the COPD assessment test (CAT) and the Clinical COPD questionnaire (CCQ) in a clinical population. COPD. 20:2016;13(1):57–65. doi:10.3109/15412555.2015.1043426. Epub 2015 Sep 14
  • SundhJ, Montgomery S, Hasselgren M, et al. Change in health status in COPD: a seven-year follow-up cohort study. NPJ Prim Care Respir Med. 2016;26:16073. doi:10.1038/npjpcrm.2016.7327763623
  • Stegberg M, Hasselgren M, Montgomery S, et al. Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD. Eur Clin Respir J. 2018;5(1):1421389. doi:10.1080/20018525.2017.142138929321831
  • Sundh J, Aberg J, Hasselgren M, et al. Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014. Eur Clin Respir J. 2017;4(1):1409060. doi:10.1080/20018525.2017.140906029230274
  • Sundh J, Lindgren H, Hasselgren M, et al. Pulmonary rehabilitation in COPD – available resources and utilization in Swedish primary and secondary care. Int J Chron Obstruct Pulmon Dis. 2017;12:1695–1704. doi:10.2147/COPD.S13511128652722
  • Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580–586.3342669
  • Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.0010250919720809
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease. Available from: http://www.goldcopd.com. Accessed November 1, 2018.
  • Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet (London, England). 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-8
  • Papaioannou AI, Bania E, Alexopoulos EC, Mitsiki E, Malli F, Gourgoulianis KI. Sex discrepancies in COPD patients and burden of the disease in females: a nationwide study in Greece (Greek obstructive lung disease epidemiology and health ecoNomics: GOLDEN study). Int J Chron Obstruct Pulmon Dis. 2014;9:203–213. doi:10.2147/COPD.S5250024600217
  • van Haren-Willems J, Heijdra Y. Increasing evidence for gender differences in chronic obstructive pulmonary disease. Womens Health (London, England). 2010;6(4):595–600. doi:10.2217/whe.10.37
  • Huang Y, Britton J, Hubbard R, Lewis S. Who receives prescriptions for smoking cessation medications? An association rule mining analysis using a large primary care database. Tob Control. 2013;22(4):274–279. doi:10.1136/tobaccocontrol-2011-05012422246781
  • Arinez-Fernandez MC, Carrasco-Garrido P, Garcia-Carballo M, Hernandez-Barrera V, de Miguel AG, Jimenez-Garcia R. Determinants of pneumococcal vaccination among patients with chronic obstructive pulmonary disease in Spain. Hum Vaccin. 2006;2(3):99–104.17012893
  • Wershof Schwartz A, Clarfield AM, Doucette JT, et al. Disparities in pneumococcal and influenza immunization among older adults in Israel: a cross-sectional analysis of socio-demographic barriers to vaccination. Prev Med. 2013;56(5):337–340. doi:10.1016/j.ypmed.2013.01.01923402962
  • Ohar J, Fromer L, Donohue JF. Reconsidering sex-based stereotypes of COPD. Prim Care Respir J. 2011;20(4):370–378. doi:10.4104/pcrj.2011.0007021922124
  • Tsiligianni I, Rodriguez MR, Lisspers K, LeeTan T, Infantino A. Call to action: improving primary care for women with COPD. NPJ Prim Care Respir Med. 2017;27(1):11. doi:10.1038/s41533-017-0013-228202995
  • Lisspers K, Ställberg B, Sundh J, Janson C Omhändertagande av patienter med kroniskt obstruktiv lungsjukdom (KOL) i Uppsala-Örebroregionen. En rapport från PRAXIS-studien astma/KOL; 2015 Available from: http://www.praxisstudien.se/texter/KOL-rapport%20mars%202015.pdf. Accessed 1021, 2018.
  • Sundh J, Stallberg B, Lisspers K, Montgomery SM, Janson C. Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD questionnaire. COPD. 2011;8(3):173–181. doi:10.3109/15412555.2011.56013021513436
  • Arne M, Lisspers K, Stallberg B, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010;104(4):550–556. doi:10.1016/j.rmed.2009.10.02319931443